Crosslinked collagen/chitosan matrix for artificial livers.

Xiaohong Wang,Dan Li,Wei Wang,Qingling Feng,Fu-zhai Cui,Yichi Xu,X. Song,Mark van der Werf

DOI: https://doi.org/10.1016/S0142-9612(03)00170-4

IF: 14

2003-08-01

Biomaterials

Abstract:

What problem does this paper attempt to address?

Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema

Kerri M. Winters-Stone,Monica Laudermilk,Kaitlin Woo,Justin C. Brown,Kathryn H. Schmitz

DOI: https://doi.org/10.1007/s11764-013-0337-z

2014-01-04

Journal of Cancer Survivorship

Abstract:PurposeThis study aimed to determine whether the Physical Activity and Lymphedema (PAL) trial weight training program for breast cancer survivors at risk of or with breast cancer-related lymphedema provided skeletal benefits.MethodsOf the 295 participants in the randomized controlled PAL trial, 258 (weight training; N = 128; control, N = 130) had complete measures of bone mineral density (BMD (in grams per square centimeter)) of the proximal femur and lumbar spine and were also categorized by T scores. Women in the weight training group performed slowly progressive weight training 2 days/week for 12 months compared to women in the control group who maintained their usual physical activities.ResultsThere were no significant differences in the rate of BMD change at any skeletal site between weight training and control groups, regardless of menopausal status. Distribution of bone health categories was not significantly different between groups at baseline, but became different at 12 months (p < 0.03) among postmenopausal women due to an increase in the percentage of controls who became osteopenic (35 to 44 %) compared to stable bone health in weight lifters.ConclusionsThe PAL weight training program that increased muscle strength without exacerbating or causing lymphedema among breast cancer survivors was not as efficacious at improving skeletal health. The skeletal loads produced from the PAL program may be insufficient to notably shift BMD, but may have a subtle osteogenic effect.Implications for cancer survivorsThe safety and efficacy of rigorous weight training programs for improving skeletal health in women at risk for or with breast cancer-related lymphedema remain to be determined.

oncology,social issues
Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial

Kathryn H Schmitz,Rehana L Ahmed,Andrea B Troxel,Andrea Cheville,Lorita Lewis-Grant,Rebecca Smith,Cathy J Bryan,Catherine T Williams-Smith,Jesse Chittams

DOI: https://doi.org/10.1001/jama.2010.1837

IF: 11.816

2010-12-22

JAMA

Abstract:Context: Clinical guidelines for breast cancer survivors without lymphedema advise against upper body exercise, preventing them from obtaining established health benefits of weight lifting. Objective: To evaluate lymphedema onset after a 1-year weight lifting intervention vs no exercise (control) among survivors at risk for breast cancer-related lymphedema (BCRL). Design, setting, and participants: A randomized controlled equivalence trial (Physical Activity and Lymphedema trial) in the Philadelphia metropolitan area of 154 breast cancer survivors 1 to 5 years postunilateral breast cancer, with at least 2 lymph nodes removed and without clinical signs of BCRL at study entry. Participants were recruited between October 1, 2005, and February 2007, with data collection ending in August 2008. Intervention: Weight lifting intervention included a gym membership and 13 weeks of supervised instruction, with the remaining 9 months unsupervised, vs no exercise. Main outcome measures: Incident BCRL determined by increased arm swelling during 12 months (≥5% increase in interlimb difference). Clinician-defined BCRL onset was also evaluated. Equivalence margin was defined as doubling of lymphedema incidence. Results: A total of 134 participants completed follow-up measures at 1 year. The proportion of women who experienced incident BCRL onset was 11% (8 of 72) in the weight lifting intervention group and 17% (13 of 75) in the control group (cumulative incidence difference [CID], -6.0%; 95% confidence interval [CI], -17.2% to 5.2%; P for equivalence = .04). Among women with 5 or more lymph nodes removed, the proportion who experienced incident BCRL onset was 7% (3 of 45) in the weight lifting intervention group and 22% (11 of 49) in the control group (CID, -15.0%; 95% CI, -18.6% to -11.4%; P for equivalence = .003). Clinician-defined BCRL onset occurred in 1 woman in the weight lifting intervention group and 3 women in the control group (1.5% vs 4.4%, P for equivalence = .12). Conclusion: In breast cancer survivors at risk for lymphedema, a program of slowly progressive weight lifting compared with no exercise did not result in increased incidence of lymphedema. Trial registration: clinicaltrials.gov Identifier: NCT00194363.
A pilot study evaluating exercise intervention and body composition changes in patients with breast cancer and survivors.

Lindsey Merifield,Chloe Asato,Kirsten Baron,Matthew Toyama,Paulette Yamada,Cheri Teranishi-Hashimoto,Jami Aya Fukui

DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.e12527

IF: 45.3

2024-06-01

Journal of Clinical Oncology

Abstract:e12527 Background: In breast cancer patients and survivors, higher weight and adipose tissue levels have been associated with cardiovascular disease, diabetes, osteoporosis, and cancer recurrence. Additionally, various breast cancer treatments can increase body weight, adipose tissue, and inflammatory markers, raising multiple health concerns for breast cancer patients. Recent studies have found exercise programs alongside breast cancer treatment decreased adipose tissue; however, the weight loss and lifestyle results were not maintained following the exercise program. It remains unclear what strategies are effective in implementing long term lifestyle changes. Methods: In this pilot study, breast cancer patients and survivors (N=24, individual=12, group=12) followed an exercise program for 6 months, followed by 6 months of follow up. Participants ranged from ages 36 to75. Participants were randomized into group and individual exercise sections. Anthropometric measurements were taken at baseline, 3 months and 1 year. One-year measures were used to indicate continued lifestyle changes. Results: Significant differences in fat % body composition were found between baseline and 3 months in both group and individual with an average change of 1.12% (5.9% max) and 1.32% (5.4% max) respectively (P=0.0090). In addition, the baseline and 1-year average change of both group 2.8% (8.8% max) and individual 1.5% (9.6% max) sections was also seen and statistically significant (P=0.0040). Patients in individual and group exercise sections had up to 9.6% and 8.8% decrease in adipose tissue over 1 year, respectively.However, no significant difference was found between the individual and group exercise sections (P=0.3244). Conclusions: Patients from both the individual and group exercise sections continued to decrease adipose tissue composition throughout the 1-year study period, including after formal exercise course cessation at 6 months. This indicates that both group and individual exercise courses may offer similar health benefits to breast cancer survivors. We are continuing long term data collection to evaluate sustainability of the intervention benefits and to monitor breast cancer recurrence rates. Clinical trial information: NCT04013568 . [Table: see text]

oncology
ODP006 Multidisciplinary Weight Management Improves Body Weight And Body Mass Composition In Breast Cancer Women Undergoing Adjuvant Chemotherapy

Vivien Nguyen,Juliana Chen,Veronica Preda

DOI: https://doi.org/10.1210/jendso/bvac150.020

2022-11-01

Journal of the Endocrine Society

Abstract:Abstract Weight gain during chemotherapy for breast cancer is a well-documented adverse side effect. The prevalence of metabolic syndrome (MetS), including glucose intolerance, hypertension and dyslipidaemia in breast cancer patients are further exacerbated by menopause. This impact on mortality is relevant as many women with early-stage breast cancer may be treated however experience a greater risk of developing chronic disease, higher rates of cancer recurrence, and post-diagnosis death. Intentional weight loss of 5-10% body weight and muscle mass preservation has found to improve metabolic markers. We evaluated how multidisciplinary weight management involving endocrinology, dietitian and exercise physiology care, in a real-life Healthy Weight Clinic (HWC) could affect body weight and mass composition outcomes in breast cancer women receiving adjuvant chemotherapy compared to a cohort of non-cancer women who have been matched by age, ethnicity, smoking and menopausal status. Body weight (kg), BMI (kg/m 2), skeletal muscle mass (SMM %), fat mass (FM %) and waist circumference (cm) were collected at three time points: baseline 0-months at the first HWC appointment, 3-months after baseline, and 6-months after baseline. A total of 32 women were included in the study, 11 in the breast cancer cohort and 21 in the control cohort. There were significant changes in weight, BMI, SMM, FM and waist circumference for the breast cancer cohort at all time intervals. By 6-months, the breast cancer women had a mean weight change of -6.99kg (SD=3.87, p=. 003, n=11) and change in BMI by -2.72kg/m 2 (SD=1.62, p=. 004, n=11). There was a change in SMM of 1.21% (SD=0.73, p=. 005, n=11), a change in FM of -2.76% (SD=1.33, p=. 002, n=11) and a change in waist circumference of -8.13cm (SD=4.21, p=. 031, n=3). The control cohort had similar trend changes in weight, BMI and waist circumference, however there was no statistically significant change in SMM or FM over time. By 6-months in the breast cancer cohort, there was a larger reduction in body weight in women who did not have MetS (-8.72kg, SD=2.41, n=6) in comparison to women with MetS (-2.65kg, SD=3.75kg, n=3) (p=. 045). For the control cohort, anthropometric outcomes were not impacted by MetS status (p>. 05). Although these findings are in a small sample size, it appears that multidisciplinary weight management has a positive role in early-stage breast cancer survival through improving body weight and mass composition outcomes. Targeting pre-existing MetS status through lifestyle changes is also an important consideration, beyond a specific weight focus. Presentation: No date and time listed
Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112

Tarah J Ballinger,Helga S Marques,Gloria Xue,Richard Hoffman,Constantine Gatsonis,Fengmin Zhao,Kathy D Miller,Joseph Sparano,Roisin M Connolly

DOI: https://doi.org/10.6004/jnccn.2023.7045

Abstract:Background: Observational data investigating the relationship between body habitus and outcomes in breast cancer have been variable and inconsistent, largely centered in the curative setting and focused on weight-based metrics. This study evaluated the impact of muscle measures on outcomes in patients with metastatic breast cancer receiving endocrine-based therapy. Methods: Baseline CT scans were collected from ECOG-ACRIN E2112, a randomized phase III placebo-controlled study of exemestane with or without entinostat. A CT cross-sectional image at the L3 level was extracted to obtain skeletal muscle mass and attenuation. Low muscle mass (LMM) was defined as skeletal muscle index <41 cm2/m2 and low muscle attenuation (LMA) as muscle density <25 HU or <33 HU if overweight/obese by body mass index (BMI). Multivariable Cox proportional hazard models determined the association between LMM or LMA and progression-free survival (PFS) and overall survival (OS). Correlations between LMM, LMA, and patient-reported outcomes were determined using 2-sample t tests. Results: Analyzable CT scans and follow-up data were available for 540 of 608 patients. LMM was present in 39% (n=212) of patients and LMA in 56% (n=301). Those with LMA were more likely to have obesity and worse performance status. LMM was not associated with survival (PFS hazard ratio [HR]: 1.13, P=.23; OS HR: 1.05, P=.68), nor was LMA (PFS HR: 1.01, P=.93; OS HR: 1.00, P=.99). BMI was not associated with survival. LMA, but not LMM, was associated with increased frequency of patient-reported muscle aches. Conclusions: Both low muscle mass and density are prevalent in patients with hormone receptor-positive metastatic breast cancer. Muscle measures correlated with obesity and performance status; however, neither muscle mass nor attenuation were associated with prognosis. Further work is needed to refine body composition measurements and select optimal cutoffs with meaningful endpoints in specific breast cancer populations, particularly those living with metastatic disease.
Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention

Christina M. Dieli-Conwright,Jean-Hugues Parmentier,Nathalie Sami,Kyuwan Lee,Darcy Spicer,Wendy J. Mack,Fred Sattler,Steven D. Mittelman

DOI: https://doi.org/10.1007/s10549-017-4576-y

2017-11-22

Breast Cancer Research and Treatment

Abstract:PurposeObesity is a leading modifiable contributor to breast cancer mortality due to its association with increased recurrence and decreased overall survival rate. Obesity stimulates cancer progression through chronic, low-grade inflammation in white adipose tissue, leading to accumulation of adipose tissue macrophages (ATMs), in particular, the pro-inflammatory M1 phenotype macrophage. Exercise has been shown to reduce M1 ATMs and increase the more anti-inflammatory M2 ATMs in obese adults. The purpose of this study was to determine whether a 16-week exercise intervention would positively alter ATM phenotype in obese postmenopausal breast cancer survivors.MethodsTwenty obese postmenopausal breast cancer survivors were randomized to a 16-week aerobic and resistance exercise (EX) intervention or delayed intervention control (CON). The EX group participated in 16 weeks of supervised exercise sessions 3 times/week. Participants provided fasting blood, dual-energy X-ray absorptiometry (DXA), and superficial subcutaneous abdominal adipose tissue biopsies at baseline and following the 16-week study period.ResultsEX participants experienced significant improvements in body composition, cardiometabolic biomarkers, and systemic inflammation (all p < 0.03 vs. CON). Adipose tissue from EX participants showed a significant decrease in ATM M1 (p < 0.001), an increase in ATM M2 (p < 0.001), increased adipose tissue secretion of anti-inflammatory cytokines such as adiponectin, and decreased secretion of the pro-inflammatory cytokines IL-6 and TNF- α (all p < 0.055).ConclusionsA 16-week aerobic and resistance exercise intervention attenuates adipose tissue inflammation in obese postmenopausal breast cancer survivors. Future large randomized trials are warranted to investigate the impact of exercise-induced reductions in adipose tissue inflammation and breast cancer recurrence.

oncology
The Impact of Multidisciplinary Weight Management on Body Weight and Body Mass Composition in Women with Breast Cancer Post-Adjuvant Chemotherapy: A Retrospective Chart Review

Vivien Nguyen,Juliana Chen,Reginald Lord,Veronica Preda

DOI: https://doi.org/10.1159/000524519

2022-04-11

Oncology

Abstract:Introduction: Weight gain during chemotherapy for breast cancer is a well-documented adverse effect. The purpose of this study was to investigate how multidisciplinary weight management involving endocrinology, dietitian and exercise physiology care, in a real-life Healthy Weight Clinic (HWC) would impact body weight and mass composition in breast cancer women post-adjuvant chemotherapy compared to a cohort of non-cancer women who have been matched by age, ethnicity, smoking and menopausal status. Methods: Body weight (kg), BMI (kg/m2), skeletal muscle mass (SMM %), fat mass (FM %) and waist circumference (cm) were collected at baseline of the first HWC appointment, three-months after baseline, and six-months after baseline. A total of 32 women were included, 11 in the breast cancer cohort and 21 in the control cohort, that matched inclusion and exclusion criteria based on a retrospective chart review from 28th July 2017 to 19th July 2021. Results: By six-months, the breast cancer women had a mean weight change of -6.99kg (SD=3.87, p=.003, n=11) and change in BMI by -2.72kg/m2 (SD=1.62, p=.004, n=11). There was a change in SMM of 1.21% (SD=0.73, p=.005, n=11), a change in FM of -2.76% (SD=1.33, p=.002, n=11) and a change in waist circumference of -8.13cm (SD=4.21, p=.031, n=3). By six-months in the breast cancer cohort, there was a larger change in body weight in women who did not have MetS (-8.72kg, SD=2.41, n=6) in comparison to women with MetS (-2.65kg, SD=3.75kg, n=3) (p=.045). Conclusion: Findings indicate that multidisciplinary weight management has a positive role in early-stage breast cancer survival through improving body weight and mass composition. These results can add to the development of long-term treatment plans for survivors in order to shine a light on ways to reduce risk recurrence and chronic disease mortality.

oncology
The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancer

Leila Mabudian,Kerry Reding,Ralph B D'Agostino Jr,Emily M Heiston,Moriah P Bellissimo,Kristine Olson,William O Ntim,Heidi D Klepin,Emily V Dressler,Tonya Moore,Jennifer H Jordan,Nathaniel S O'Connell,Amy Ladd,Kathryn E Weaver,Bonnie Ky,Lynne I Wagner,Mary Helen Hackney,Glenn J Lesser,W Gregory Hundley,UPBEAT Study Team

DOI: https://doi.org/10.1186/s40959-024-00233-1

2024-06-06

Abstract:Background: To understand how body composition in those with elevated body mass index impacts left ventricular function decline during cancer treatment, we determined the association between baseline body mass index (BMI), intra-abdominal adipose tissue (IAT) and subcutaneous adipose tissue (SAT) with baseline to 3-month left ventricular ejection fraction (LVEF) change among women receiving potentially cardiotoxic chemotherapy for breast cancer, lymphoma, or sarcoma. Methods: Women underwent potentially cardiotoxic chemotherapy, such as doxorubicin, cyclophosphamide, paclitaxel, and trastuzumab, for treatment of breast cancer, lymphoma, or sarcoma. We obtained magnetic resonance images (MRIs) of body composition and cardiac function prior to treatment, and then a repeat MRI for cardiac function assessment at three months into treatment. Analyses and assessment of abdominal adipose tissue volumes and LVEF outcomes were conducted by independent reviewers blinded to all patient identifiers. A general linear model was created to examine associations between adipose tissue depots, BMI, and 3-month LVEF change. Results: Women (n = 210) aged 56 ± 11 years with breast cancer, lymphoma, and sarcoma were enrolled (n = 195, 14, 1 respectively). Baseline BMI, IAT, and SAT fat were independently associated with 3-month LVEF declines (p = 0.001 to 0.025 for all). After adjusting for baseline cardiovascular disease risk factors, BMI, IAT, and SAT, BMI remained the only variable associated with 3-month LVEF decline (p = 0.047). Conclusions: These results suggest that factors other than abdominal adipose tissue or traditional cardiovascular risk factors may contribute to 3-month declines in LVEF among women with elevated BMI receiving potentially cardiotoxic chemotherapy. Further investigation should be conducted on psychosocial stress, physical activity, sleep, or diet. Trial registration: DETECTIV_NCT01719562, WF99112, & WF97415-NCT02791581.
Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial

Christina M Dieli-Conwright,Kerry S Courneya,Wendy Demark-Wahnefried,Nathalie Sami,Kyuwan Lee,Frank C Sweeney,Christina Stewart,Thomas A Buchanan,Darcy Spicer,Debu Tripathy,Leslie Bernstein,Joanne E Mortimer

DOI: https://doi.org/10.1186/s13058-018-1051-6

2018-10-19

Breast Cancer Research

Abstract:BackgroundExercise is an effective strategy to improve quality of life and physical fitness in breast cancer survivors; however, few studies have focused on the early survivorship period, minorities, physically inactive and obese women, or tested a combined exercise program and measured bone health. Here, we report the effects of a 16-week aerobic and resistance exercise intervention on patient-reported outcomes, physical fitness, and bone health in ethnically diverse, physically inactive, overweight or obese breast cancer survivors.MethodsOne hundred breast cancer survivors within 6 months of completing adjuvant treatment were assessed at baseline, post-intervention, and 3-month follow-up (exercise group only) for physical fitness, bone mineral density, serum concentrations of bone biomarkers, and quality of life. The exercise intervention consisted of moderate-vigorous (65–85% heart rate maximum) aerobic and resistance exercise thrice weekly for 16 weeks. Differences in mean changes for outcomes were evaluated using mixed-model repeated measure analysis.ResultsAt post-intervention, the exercise group was superior to usual care for quality of life (between group difference: 14.7, 95% CI: 18.2, 9.7; p < 0.001), fatigue (p < 0.001), depression (p < 0.001), estimated VO2max (p < 0.001), muscular strength (p < 0.001), osteocalcin (p = 0.01), and BSAP (p = 0.001). At 3-month follow-up, all patient-reported outcomes and physical fitness variables remained significantly improved compared to baseline in the exercise group (p < 0.01).ConclusionsA 16-week combined aerobic and resistance exercise program designed to address metabolic syndrome in ethnically-diverse overweight or obese breast cancer survivors also significantly improved quality of life and physical fitness. Our findings further support the inclusion of supervised clinical exercise programs into breast cancer treatment and care.Trial registrationThis trial is registered on ClinicalTrials.gov: NCT01140282 as of June 9, 2010.

oncology
A protocol for remote collection of skeletal muscle mass via D3-creatine dilution in community-dwelling postmenopausal women from the Women’s Health Initiative

Hailey R. Banack,Jean Wactawski-Wende,Heather M. Ochs-Balcom,Elizabeth M. Cespedes Feliciano,Bette Caan,Catherine Lee,Garnet Anderson,Mahalakshmi Shankaran,William J. Evans

DOI: https://doi.org/10.1371/journal.pone.0300140

IF: 3.7

2024-04-17

PLoS ONE

Abstract:Background There is emerging evidence that cancer and its treatments may accelerate the normal aging process, increasing the magnitude and rate of decline in functional capacity. This accelerated aging process is hypothesized to hasten the occurrence of common adverse age-related outcomes in cancer survivors, including loss of muscle mass and decrease in physical function. However, there is no data describing age-related loss of muscle mass and its relation to physical function in the long-term in cancer survivors. Methods This study protocol describes the use of a novel method of muscle mass measurement, D3-creatine dilution method (D 3 Cr), in a large sample (n~6000) of community dwelling postmenopausal women from the Women’s Health Initiative (WHI). D 3 Cr will be used to obtain a direct measure of muscle mass remotely. Participants will be drawn from two sub-cohorts embedded within the WHI that have recently completed an in-home visit. Cancer survivors will be drawn from the Life and Longevity After Cancer (LILAC) cohort, and cancer-free controls will be drawn from the WHI Long Life Study 2. The overall objective of this study is to examine the antecedents and consequences of low muscle mass in cancer survivors. The study aims are to: 1) create age-standardized muscle mass percentile curves and z-scores to characterize the distribution of D3- muscle mass in cancer survivors and non-cancer controls, 2) compare muscle mass, physical function, and functional decline in cancer survivors and non- cancer controls, and 3) use machine learning approaches to generate multivariate risk-prediction algorithms to detect low muscle mass. Discussion The D 3 Cr method will transform our ability to measure muscle mass in large-scale epidemiologic research. This study is an opportunity to advance our understanding of a key source of morbidity among older and long-term female cancer survivors. This project will fill knowledge gaps, including the antecedents and consequences of low muscle mass, and use innovative methods to overcome common sources of bias in cancer research. The results of this study will be used to develop interventions to mitigate the harmful effects of low muscle mass in older adults and promote healthy survivorship in cancer survivors in the old (>65) and oldest-old (>85) age groups.

multidisciplinary sciences
Preliminary analysis of the THRIVE clinical trial on the effect of resistance exercise on skeletal muscle bioenergetics, strength and body composition in breast cancer survivors

Emily Arentson-Lantz,Noah Sanchez,Geoffrey Clarke,Chrisann Moon,Darpan Patel

DOI: https://doi.org/10.1152/physiol.2024.39.s1.1649

IF: 11.8461

2024-05-01

Physiology

Abstract:Objective: Breast cancer survivors (BCS) are at high risk for loss in skeletal muscle mass, which can be exacerbated by cancer treatment and tumor related factors. While resistance exercise has been shown to be effective in improving strength and physical function in BCS, little is known as to how exercise modulates skeletal muscle bioenergetics in oncology populations. Uncovering these factors are critical for explaining adaptations to exercise among cancer survivors. Therefore, the objective of the THRIVE clinical trial is to determine the effects of resistance exercise training on modulating skeletal muscle bioenergetics in BCS. Hypothesis: We hypothesized that 12 weeks of resistance exercise would improve skeletal muscle bioenergetics, strength and body composition in BCS. Methodology: Preliminary analysis was performed on BCS (n=10; 45.7 ± 11.5 yr) who had completed chemotherapy within the previous 6 months and were recruited to complete 12 weeks of progressive, home-based resistance exercise program (3 supervised training bouts per week). Baseline and 12 weeks strength was assessed with isometric dynamometry and 1 rep max (RM) testing, body composition was measured with DEXA, and physical function was assessed with a 6 minute walk test. Changes in muscle bioenergetics, specifically changes in resting phosphorus metabolites, were assessed using 31-phosphorus magnetic resonance spectroscopy. In the original study design, participants were randomized to either receive creatinine supplement + exercise (n=5) or exercise alone (n=5); however, there were no significant differences between the interventions on the primary outcomes reported here, so the intervention groups were collapsed. Data: Handgrip strength, 1 RM chest press, 1 RM bicep curl, 1 RM leg press and 1 RM leg extension significantly increased (p<0.05) following 12 weeks of training in breast cancer survivors. Twelve weeks of resistance exercise training also significantly increased skeletal muscle phosphodiester (PDE) content and tended to increase total phosphocreatine and gammaATP. There were no significant changes in isometric knee strength, fat mass, lean mass, 6 minute walk testing distance or skeletal muscle inorganic phosphorous. Summary: This preliminary analysis indicates changes in strength and skeletal muscle bioenergetics occur in BCS following a 12-week home-based resistance exercise intervention. Further research is needed to validate these results. The ThriveWell Foundation, NIH (P30 CA054174 and P30 AG044271). This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

physiology
Effects on the Physical Functioning of Two Exercise Interventions in Patients with Multiple Myeloma: A Pilot Feasibility Study

Jens Hillengass,Michaela Hillengass,Janine M. Joseph,Kristopher Attwood,Rikki Cannioto,Hillary Jacobson,Carolyn Miller,Bryan Wittmeyer,Kirsten Moysich

DOI: https://doi.org/10.3390/cancers16091774

2024-05-04

Cancers

Abstract:Because of the high prevalence of bone destruction in patients with multiple myeloma (MM), physical exercise is oftentimes discouraged by healthcare providers. The goal of this prospective trial was to investigate the feasibility of two six-month exercise interventions in patients with MM (N = 42): a remotely prompted home-based walking intervention or a supervised strength training intervention. Physical function and pain were assessed with the Activity Measure for Post-Acute Care (AM-PAC) Basic Mobility Short Form raw score, a six-minute walk test (6 MWT), a 30-second sit-to-stand test (30 SST), a timed up-and-go (TUG) test, a visual analog scale (VAS) for pain, handheld dynamometer tests, heart rate at rest, blood oxygen saturation at rest, and body mass index. No intervention-related serious adverse events were observed. Adverse events mostly affected the musculoskeletal system. In the resistance training group (n = 24), patients showed significant improvements in AM-PAC, TUG, 6 MWT, and 30 SST, with all effects but the 6 MWT sustained six months after the intervention. The walking group (n = 18) saw improvements in the AM-PAC, TUG, 6 MWT, and 30 SST, with a sustained change in the AM-PAC and TUG. This trial shows the feasibility of both exercise interventions with a sustained beneficial effect on the physical functioning of a six-month strength training intervention and, to a lesser extent, a six-month unsupervised walking intervention. A larger study building on these findings is currently underway.

oncology
Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors

Christina M. Dieli-Conwright,Maura Harrigan,Brenda Cartmel,Anees Chagpar,Yalai Bai,Fang-yong Li,David L. Rimm,Lajos Pusztai,Lingeng Lu,Tara Sanft,Melinda L. Irwin

DOI: https://doi.org/10.1038/s41523-022-00396-z

2022-03-07

npj Breast Cancer

Abstract:Abstract Few trials have examined the effect of lifestyle behavioral interventions on tissue markers in patients with cancer. The purpose of this study was to examine the feasibility and impact of a 6-month weight loss intervention on breast tissue and serum biomarkers in women with breast cancer. Fifty-one women who completed breast cancer treatment and had a BMI ≥ 25.0 kg/m 2 were randomized to a weight loss intervention or usual care. Breast tissue biopsies, fasting blood draw and body composition were collected at baseline and 6 months, with between-group changes examined using analysis of covariance method. Baseline and post-intervention biopsies were conducted in 49 and 42 women, respectively, with pre- and post-epithelial tissue available from 25 tissue samples. Average 6-month weight loss was 6.7% for the weight loss group and 2.0% increase for the usual care group ( p < 0.0001). At baseline, body fat and serum insulin levels were inversely associated with breast tissue insulin receptor levels and CD68 ( p < 0.05). At 6 months, favorable changes were observed in serum leptin and adiponectin levels and tissue CD163 among women randomized to weight loss vs. adverse change in women randomized to usual care ( p < 0.05). Breast tissue biopsies are feasible to collect in a clinical research setting among breast cancer survivors, with weight loss favorably impacting metabolic and inflammatory markers associated with breast cancer.

oncology
Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial

Sharon L. Kilbreath,Kathryn M. Refshauge,Jane M. Beith,Leigh C. Ward,MiJoung Lee,Judy M. Simpson,Ross Hansen

DOI: https://doi.org/10.1007/s10549-012-1964-1

2012-01-29

Breast Cancer Research and Treatment

Abstract:The aim of this study was to determine whether an exercise program, commencing 4–6 weeks post-operatively, reduces upper limb impairments in women treated for early breast cancer. Women (n = 160) were randomized to either an 8-week exercise program (n = 81) or to a control group (n = 79) following stratification for axillary surgery. The exercise program comprised a weekly session and home program of passive stretching and progressive resistance training for shoulder muscles. The control group attended fortnightly assessments but no exercises were provided. The primary outcome was self-reported arm symptoms derived from the EORTC breast cancer-specific questionnaire (BR23), scored out of 100 with a low score indicative of fewer symptoms. The secondary outcomes included physical measures of shoulder range of motion, strength, and swelling (i.e., lymphedema). Women were assessed immediately following the intervention and at 6 months post-intervention. The change in symptoms from baseline was not significantly different between groups immediately following the intervention or at 6 m post-intervention. The between group difference immediately following the intervention was 4 (95% CI −1 to 9) and 6 months post-intervention was 4 (−2 to 10). However, the change in range of motion for flexion and abduction was significantly greater in the exercise group immediately following the intervention, as was change in shoulder abductor strength. In conclusion, a supervised exercise program provided some, albeit small, additional benefit at 6 months post-intervention to women who had been provided with written information and reminders to use their arm. Both the groups reported few impairments including swelling immediately following the intervention and 6 months post-intervention. Notably, resistance training in the post-operative period did not precipitate lymphedema.

oncology
Effect of resistance exercise in postmastectomy breast cancer survivors: A systematic review

Abhishek Sharma,Sakshi Vats,Aksh Chahal

DOI: https://doi.org/10.4103/jdmimsu.jdmimsu_422_22

2023-09-01

Journal of Datta Meghe Institute of Medical Sciences University

Abstract:Abhishek Sharma, Sakshi Vats, Aksh Chahal Journal of Datta Meghe Institute of Medical Sciences University 2023 18(3):539-548 Background: Breast cancer (BC) impacts over 1.2 million individuals every year worldwide and is the most frequently diagnosed illness in women. Medical treatment options have increased chances of survival, but these procedures frequently have side effects that can negatively impact health status and quality of life (QoL) over the long term QoL. Given that resistance exercise has a special anabolic effect; it may be useful for addressing the effects of BC and its therapy. Materials and Methods: This is an integrative literature review study that includes data search from PubMed, MEDLINE, Scopus, Google Scholar, and the physiotherapy evidence database databases for articles and also crossing English descriptors indexed in the medical subject headings and health sciences descriptors, respectively. The present review is based on the Whittemore and Knafl methodology. Results: A total of 842 patients from 13 studies were included. There was no aggravation subjectively reported or objectively evaluated lymphedema symptoms. Adverse effects were uncommon, mostly of a musculoskeletal in nature, and were successfully handled using conservative methods. The studies we looked at indicate that women who had BC surgically treated can benefit from resistance exercise in terms of their clinical and health outcomes. Results demonstrate that in cancer survivors, pain, physical and emotional functioning, fatigue, depression, and aerobic capacity have improved. Conclusion: It is necessary to conduct rigorously constructed randomized controlled trials (RCTs) that recommend targeted resistance exercise regimens at various stages of BC treatment. To demonstrate the effectiveness of this intervention for the posttreatment care of BC patients and survivors as a method of enhancing health status and QoL, RCTs with complete, standardized reporting of interventions, and adverse events are necessary.
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial

Anouk E. Hiensch,Johanna Depenbusch,Martina E. Schmidt,Evelyn M. Monninkhof,Mireia Pelaez,Dorothea Clauss,Nadira Gunasekara,Philipp Zimmer,Jon Belloso,Mark Trevaskis,Helene Rundqvist,Joachim Wiskemann,Jana Müller,Maike G. Sweegers,Carlo Fremd,Renske Altena,Maciej Gorecki,Rhodé Bijlsma,Lobke van Leeuwen-Snoeks,Daan ten Bokkel Huinink,Gabe Sonke,Ainhara Lahuerta,G. Bruce Mann,Prudence A. Francis,Gary Richardson,Wolfram Malter,Elsken van der Wall,Neil K. Aaronson,Elzbieta Senkus,Ander Urruticoechea,Eva M. Zopf,Wilhelm Bloch,Martijn M. Stuiver,Yvonne Wengstrom,Karen Steindorf,Anne M. May

DOI: https://doi.org/10.1038/s41591-024-03143-y

IF: 82.9

2024-07-26

Nature Medicine

Abstract:Physical exercise both during and after curative cancer treatment has been shown to reduce side effects. Evidence in the metastatic cancer setting is scarce, and interventions that improve health-related quality of life (HRQOL) are much needed for patients with metastatic breast cancer (MBC). The multinational randomized controlled PREFERABLE-EFFECT trial assessed the effects of exercise on fatigue and HRQOL in patients with MBC. In total, 357 patients with MBC and a life expectancy of ≥6 months but without unstable bone metastases were recruited at eight study centers across five European countries and Australia. Participants were randomly assigned (1:1) to usual care (control group, n = 179) or a 9-month supervised exercise program (exercise group, n = 178). Intervention effects on physical fatigue (European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ)-FA12 scale) and HRQOL (EORTC QLQ-C30 summary score) were determined by comparing the change from baseline to 3, 6 (primary timepoint) and 9 months between groups using mixed models for repeated measures, adjusted for baseline values of the outcome, line of treatment (first or second versus third or higher) and study center. Exercise resulted in significant positive effects on both primary outcomes. Physical fatigue was significantly lower (−5.3 (95% confidence interval (CI), −10.0 to −0.6), Bonferroni–Holm-adjusted P = 0.027; Cohen's effect size, 0.22) and HRQOL significantly higher (4.8 (95% CI, 2.2–7.4), Bonferroni–Holm-adjusted P = 0.0003; effect size, 0.33) in the exercise group than in the control group at 6 months. Two serious adverse events occurred (that is, fractures), but both were not related to bone metastases. These results demonstrate that supervised exercise has positive effects on physical fatigue and HRQOL in patients with MBC and should be recommended as part of supportive care.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Increased skeletal intermuscular fat is associated with reduced exercise capacity in cancer survivors: a cross-sectional study

Kerryn W. Reding,Peter Brubaker,Ralph D’Agostino,Dalane W. Kitzman,Barbara Nicklas,Dale Langford,Michael Grodesky,W. Gregory Hundley

DOI: https://doi.org/10.1186/s40959-019-0038-5

2019-05-03

Abstract:BackgroundCancer survivors experience on average a 20% reduction in peak exercise capacity (VO2 peak) post-cancer treatment. Intermuscular fat (IMF) is a strong predictor of reduced exercise capacity in heart failure (HF) patients; however it is unknown whether increased IMF is related to reduced VO2 peak in cancer survivors.Methods and resultsTwenty eight individuals: 14 cancer survivors > 12-months post-cancer treatment and 14 individuals without cancer were matched on age, gender, and body mass index (BMI). Participants underwent magnetic resonance imaging (MRI) assessments of IMF within the paraspinal muscles, VO2 peak and exercise-associated measures of left ventricular ejection fraction (LVEF). Blinded analyses were performed. Associations between the ratio of IMF to skeletal muscle (SM) were estimated using Pearson’s partial correlation coefficients. Individuals with cancer and non-cancer comparators were of similar age (54 ± 17 versus 54 ± 15 years; p = 1.0), gender (5 men and 9 women, both groups), and BMI (27 ± 4 versus 26 ± 4; p = 0.57). Peak VO2 was 22% lower in cancer survivors versus non-cancer comparators (26.9 vs 34.3 ml/kg/min; p = 0.005), and was correlated with IMF:SM in both cancer survivors and non-cancer individuals after accounting for exercise-associated LVEF, resting LVEF, BMI, other body fat depots, and cardiovascular disease (CVD) co-morbidities (p < 0.001 to 0.08 for all adjusted correlations).ConclusionAmong cancer survivors that previously received anthracyclines, increased intermuscular fat is associated with reduced VO2 peak even after accounting for exercise-associated cardiac function. This suggests IMF is important in the development of exercise intolerance, an outcome experienced by a large number of cancer survivors.
A randomized cross-over trial to detect differences in arm volume after low- and heavy-load resistance exercise among patients receiving adjuvant chemotherapy for breast cancer at risk for arm lymphedema: study protocol

Kira Bloomquist,Sandi Hayes,Lis Adamsen,Tom Møller,Karl Bach Christensen,Bent Ejlertsen,Peter Oturai

DOI: https://doi.org/10.1186/s12885-016-2548-y

IF: 4.638

2016-07-22

BMC Cancer

Abstract:Background: In an effort to reduce the risk of breast cancer-related arm lymphedema, patients are commonly advised to avoid heavy lifting, impacting activities of daily living and resistance exercise prescription. This advice lacks evidence, with no prospective studies investigating arm volume changes after resistance exercise with heavy loads in this population. The purpose of this study is to determine acute changes in arm volume after a session of low- and heavy-load resistance exercise among women undergoing adjuvant chemotherapy for breast cancer at risk for arm lymphedema. Methods/design: This is a randomized cross-over trial. Participants: Women receiving adjuvant chemotherapy for breast cancer who have undergone axillary lymph node dissection will be recruited from rehabilitation centers in the Copenhagen area. Intervention: Participants will be randomly assigned to engage in a low- (two sets of 15-20 repetition maximum) and heavy-load (three sets of 5-8 repetition maximum) upper-extremity resistance exercise session with a one week wash-out period between sessions. Outcome: Changes in extracellular fluid (L-Dex score) and arm volume (ml) will be assessed using bioimpedance spectroscopy and dual-energy x-ray absorptiometry, respectively. Symptom severity related to arm lymphedema will be determined using a visual analogue scale (heaviness, swelling, pain, tightness). Measurements will be taken immediately pre- and post-exercise, and 24- and 72-hours post-exercise. Sample size: A sample size of 20 participants was calculated based on changes in L-Dex scores between baseline and 72-hours post exercise sessions. Discussion: Findings from this study are relevant for exercise prescription guidelines, as well as recommendations regarding participating in activities of daily living for women following surgery for breast cancer and who may be at risk of developing arm lymphedema. Trial registration: Current Controlled Trials ISRCTN97332727 . Registered 12 February 2015.
Body weight management in overweight and obese breast cancer survivors

Hassan Shaikh,Peter Bradhurst,Li Xin Ma,Sim Yee Cindy Tan,Sam J Egger,Janette L Vardy

DOI: https://doi.org/10.1002/14651858.cd012110.pub2

IF: 8.4

2020-12-11

Cochrane Database of Systematic Reviews

Abstract:BACKGROUND: Studies suggest that overweight and obese breast cancer survivors are at increased risk of cancer recurrence and have higher all-cause mortality. Obesity has an impact on breast cancer survivor's quality of life (QOL) and increases the risk of longer-term morbidities such as type 2 diabetes mellitus and cardiovascular disease. Many cancer guidelines recommend survivors maintain a healthy weight but there is a lack of evidence regarding which weight loss method to recommend.OBJECTIVES: To assess the effects of different body weight loss approaches in breast cancer survivors who are overweight or obese (body mass index (BMI) ≥ 25 kg/m2).SEARCH METHODS: We carried out a search in the Cochrane Breast Cancer Group's (CBCG's) Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 6), MEDLINE (2012 to June 2019), Embase (2015 to June 2019), the World Health Organisation International Clinical Trials Registry Platform (WHO ICTRP) and Clinicaltrials.gov on 17 June 2019. We also searched Mainland Chinese academic literature databases (CNKI), VIP, Wan Fang Data and SinoMed on 25 June 2019. We screened references in relevant manuscripts.SELECTION CRITERIA: We included randomised controlled trials (RCTs), quasi-RCTs and randomised cross-over trials evaluating body weight management for overweight and obese breast cancer survivors (BMI ≥ 25 kg/m2). The aim of the intervention had to be weight loss.DATA COLLECTION AND ANALYSIS: Two review authors independently performed data extraction and assessed risk of bias for the included studies, and applied the quality of the evidence using the GRADE approach. Dichotomous outcomes were analysed as proportions using the risk ratio (RR) as the measure of effect. Continuous data were analysed as means with the measure of effect being expressed as the mean differences (MDs) between treatment groups in change from baseline values with 95% confidence intervals (CIs), when all studies reported exactly the same outcomes on the same scale. If similar outcomes were reported on different scales the standardised mean difference (SMD) was used as the measure of effect. Quality of life data and relevant biomarkers were extracted where available.MAIN RESULTS: We included a total of 20 studies (containing 23 intervention-comparisons) and analysed 2028 randomised women. Participants in the experimental groups received weight loss interventions using the core element of dietary changes, either in isolation or in combination with other core elements such as 'diet and exercise', 'diet and psychosocial support' or 'diet, exercise and psychosocial support'. Participants in the controls groups either received usual care, written materials or placebo, or wait-list controls. The duration of interventions ranged from 0.5 months to 24 months. The duration of follow-up ranged from three months to 36 months. There were no time-to-event data available for overall survival, breast cancer recurrence and disease-free survival. There was a relatively small amount of data available for breast cancer recurrence (281 participants from 4 intervention-comparisons with 14 recurrence events; RR 1.95, 95% CI 0.68 to 5.60; low-quality evidence) and the analysis was likely underpowered. Overall, we found low-quality evidence that weight loss interventions for overweight and obese breast cancer survivors resulted in a reduction in body weight (MD: -2.25 kg, 95% CI: -3.19 to -1.3 kg; 21 intervention-comparisons; 1751 women), body mass index (BMI) (MD: -1.08 kg/m2, 95% CI: -1.61 to -0.56 kg/m2; 17 intervention-comparisons; 1353 women), and waist circumference (MD:-1.73 cm, 95% CI: -3.17 to -0.29 cm; 13 intervention-comparisons; 1193 women), and improved overall quality of life (SMD: 0.74; 95% CI: 0.20 to 1.29; 10 intervention-comparisons; 867 women). No increase was seen in adverse events for women in the intervention groups compared to controls (RR 0.94, 95% CI: 0.76 to 1.17; 4 intervention-comparisons; 394 women; high-quality evidence). Subgroup analyses revealed that decreases in body weight, BMI and waist circumference were present in women regardless of their ethnicity and menopausal status. Multimodal weight loss interventions (which referred to 'diet, exercise and psychosocial support') appeared to result in greater reductions in body weight (MD: -2.88 kg, 95% CI: -3.98 to -1.77 kg; 13 intervention-comparisons; 1526 participants), BMI (MD: -1.44 kg/m2, 95% CI: -2.16 to -0.72 kg/m2; 11 studies; 1187 participants) and waist circumference (MD:-1.66 cm, 95% CI: -3.49 to -0.16 cm; 8 intervention-comparisons; 1021 participants) compared to dietary change alone, however the evidence was low quality.AUTHORS' CONCLUSIONS: Weight loss interventions, particularly multimodal interventions (incorporating diet, exercise and psychosocial support), in overweight or obese breast cancer survivors appear to result in decreases in body weight, BMI and waist circumference and improvement in overall quality of life. There was no increase in adverse events. There is a lack of data to determine the impact of weight loss interventions on survival or breast cancer recurrence. This review is based on studies with marked heterogeneity regarding weight loss interventions. Due to the methods used in included studies, there was a high risk of bias regarding blinding of participants and assessors. Further research is required to determine the optimal weight loss intervention and assess the impact of weight loss on survival outcomes. Long-term follow-up in weight loss intervention studies is required to determine if weight changes are sustained beyond the intervention periods.

medicine, general & internal
Physical activity levels of overweight or obese breast cancer survivors: correlates at entry into a weight loss intervention study

Fred X Liu,Shirley W Flatt,Bilgé Pakiz,Rebecca L Sedjo,Kathleen Y Wolin,Cindy K Blair,Wendy Demark-Wahnefried,Cheryl L Rock

DOI: https://doi.org/10.1007/s00520-015-2761-2

Abstract:Purpose: Physical activity is associated with reduced risk and progression of breast cancer, and exercise can improve physical function, quality of life, and fatigue in cancer survivors. Evidence on factors associated with cancer survivors' adherence to physical activity guidelines from the American Cancer Society and the U.S. Department of Health and Human Services is mixed. This study seeks to help fill this gap in knowledge by examining correlates with physical activity among breast cancer survivors. Methods: Overweight or obese breast cancer survivors (N = 692) were examined at enrollment into a weight loss intervention study. Questionnaires and medical record review ascertained data on education, race, ethnicity, menopausal status, physical activity, and medical history. Measures of anthropometrics and fitness level were conducted. Regression analysis examined associations between physical activity and demographic, clinical, and lifestyle factors. Results: Overall, 23% of women met current guidelines. Multivariate analysis revealed that body mass index (p = 0.03), emergency room visits in the past year (p = 0.04), and number of comorbidities (p = 0.02) were associated with less physical activity. Geographic region also was associated with level of physical activity (p = 0.02), with women in Alabama reporting significantly less activity than those in other participating regions. Conclusions: The majority of overweight/obese breast cancer survivors did not meet physical activity recommendations. Physical activity levels were associated with degree of adiposity, geographic location, and number of comorbidities. The majority of overweight breast cancer survivors should be encouraged to increase their level of physical activity. Individualizing exercise prescriptions according to medical comorbidities may improve adherence.

Crosslinked collagen/chitosan matrix for artificial livers.

Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema

Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial

A pilot study evaluating exercise intervention and body composition changes in patients with breast cancer and survivors.

ODP006 Multidisciplinary Weight Management Improves Body Weight And Body Mass Composition In Breast Cancer Women Undergoing Adjuvant Chemotherapy

Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112

Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention

The Impact of Multidisciplinary Weight Management on Body Weight and Body Mass Composition in Women with Breast Cancer Post-Adjuvant Chemotherapy: A Retrospective Chart Review

The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancer

Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial

A protocol for remote collection of skeletal muscle mass via D3-creatine dilution in community-dwelling postmenopausal women from the Women’s Health Initiative

Preliminary analysis of the THRIVE clinical trial on the effect of resistance exercise on skeletal muscle bioenergetics, strength and body composition in breast cancer survivors

Effects on the Physical Functioning of Two Exercise Interventions in Patients with Multiple Myeloma: A Pilot Feasibility Study

Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors

Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial

Effect of resistance exercise in postmastectomy breast cancer survivors: A systematic review

Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial

Increased skeletal intermuscular fat is associated with reduced exercise capacity in cancer survivors: a cross-sectional study

A randomized cross-over trial to detect differences in arm volume after low- and heavy-load resistance exercise among patients receiving adjuvant chemotherapy for breast cancer at risk for arm lymphedema: study protocol

Body weight management in overweight and obese breast cancer survivors

Physical activity levels of overweight or obese breast cancer survivors: correlates at entry into a weight loss intervention study